Powerful HIV-1 Genotyping and Drug Resistance Detection Solution
Description
Comprehensive, sensitive and accurate HIV-1 genotyping and DRM detection
HIV drug resistance (HIVDR) is a major global challenge, hindering the effectiveness of antiretroviral therapy (ART) and causing treatment failure in HIV patients. Next-Generation Sequencing (NGS) offers a game-changing solution by providing:
- Scalable Throughput: Process a high volume of samples efficiently.
- Increased Sensitivity: Detect low-frequency drug resistance mutations.
- Enhanced Accuracy: Ensure reliable results for informed treatment decisions.
Introducing MGI's HIV-1 Drug Resistance Workflow:
MGI's comprehensive solution streamlines the process of characterizing HIV drug resistance in both plasma and culture specimens. Powered by deep sequencing, it offers:
- Low-Frequency Mutation Detection: Identify even rare mutations that could impact treatment.
- Streamlined Workflow: Combine automated sample preparation with user-friendly HIV-GenomePro software for a smooth experience.
- Fast and Accurate Results: Enable rapid decision-making for optimal patient care.
HIV-1 Drug Resistance Sequencing workflow